With no cure on the horizon, neuroprotective strategies may be the best option for this neurodegenerative disease. Medscape Ophthalmology
Author: Medscape
Pivotal AMD Treatment Studies Update
Results of treatment trials for exudative AMD and choroidal neovascularization are summarized. Medscape Ophthalmology
Consumers Overconfident About Eye Health
Consumers confidently hold many mistaken beliefs about eye health. This results in risky behaviors and neglect that could endanger vision and overall health. Medscape Medical News
Fluocinolone Inserts Helpful in Diabetic Macular Edema
In patients with diabetic macular edema (DME), fluocinolone acetonide (FAc) vitreous inserts worked well for up to three years in a recent study. Reuters Health Information
Phacoemulsification Complications Declining
Between 1989 and 2001, rates of retinal detachment plummeted after introduction of a new procedure for correcting cataracts. Medscape Medical News
Remote Based Computerized Visual Acuity Measurement
Are remote visual acuity tests as effective as those done in person by a clinician? This new study investigates. The British Journal of Ophthalmology
Smartphones May Aid Eye Diagnoses in the ER
Sending patient images to ophthalmologists via smartphone may be an option for emergency room doctors looking to make a quick eye-related diagnosis. Reuters Health Information
Bevacizumab Shows No Benefit in Advanced-Stage AMD
Intravitreal bevacizumab does not benefit patients with advanced neovascular age-related macular degeneration (AMD) and very poor vision, according to a small study. Reuters Health Information
Two Popular Aqueous Shunts: Which Is Better?
This F1000 commentary reviews a landmark Ahmed Versus Baerveldt (AVB) study that compares the safety and efficacy of the 2 most popular aqueous shunts. Faculty of 1000
Two Popular Aqueous Shunts: Which Is Better?
Ranibizumab and Bevacizumab Equally Effective Against AMD
The drugs were equally effective in eliminating the fluid associated with neovascular AMD in a randomized controlled trial; monthly dosing was more effective than as-needed dosing. Medscape Medical News
Retinal Disease: Advances in Treatment
Drs. Roger Steinert and Barry Kuppermann review the latest study results in retinal disease as presented during ARVO 2012. How will they translate into clinical practice? Medscape Ophthalmology
VEGF Inhibitors for Macular Degeneration Not Tied to Stroke
Vascular endothelial growth factor (VEGF) inhibitors used for age-related macular degeneration did not increase patients’ risk of stroke in a population-based study in Canada. Reuters Health Information
Retinal Disease: Advances in Treatment
Glaucoma Co-management: Interprofessional Agreement
How can ophthalmologists and optometrists work together to ensure that glaucoma patients receive the best and most comprehensive care? Eye
Sharp Rise in Adult Eye Diseases as Baby Boomers Age
Report outlines the estimated prevalence of age-related eye diseases in the United States. Data show an estimated 89% increase in diabetic retinopathy among people age 40 and older since 2000. Medscape Medical News
Corneal Crosslinking: What We Know, What We Don’t Know
Dr. Roger Steinert delves into corneal crosslinking, a subject getting a lot of attention recently. What is it we know, don’t know, and hope to know about this novel procedure? Medscape Ophthalmology
Corneal Crosslinking: What We Know, What We Dont Know
Is Failed ‘Big Bubble’ DALK Really as Good?
And what is the most reasonable alternative when ‘big bubble’ is not achieved? Medscape Ophthalmology
Variability in IOP in Glaucoma and Ocular Hypertension
How often should intraocular pressure measurements be taken in patients with glaucoma and ocular hypertension? Does timing matter? The British Journal of Ophthalmology